1Chen J, Muntner P, Hamm LL, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol, 2003, 14: 469-477.
2Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol, 2005, 16: 489-495.
3Rasic- Milutinovic Z, Perunicic G, Pljesa S, et al. Is insulin independent predictor of mortality in hemodialysis patients. Yugoslav Medical Biochemistry, 2004, 23: 43-49.
4Shoji T, Emoto M, Nishizawa Y.HOMA index to assess insulin resistance in renal failure patients. Nephron, 2001, 89: 348-349.
5Deb DK, Chen Y, Zhang Z, et al. 1,25- Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF- kappa B pathway. Am J Physiol Renal Physiol, 2009, 296: 1212-1218.
6Lee S, Lee DK, Choi E, et al. Identification of a functional vitamin D response element in the murine Insig-2 promoter and its potential role in the differentiation of 3T3- LI predipocytes. Mol Edocrinol, 2005, 19: 399-408.
7Ashraf A, Mick G, Meleth S, et al. Insulin treatment reduces pre -prandial plasma ghrelin concentrations in childrenwith type 1 diabetes. Med Sci Monit, 2007, 13: 533-537.
8Giulietti A, van Etten E, Overbergh L, et al. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25- Dihydroxyvitamin D(3) works as anti- inflammatory. Diabetes Res Clin Pract, 2007, 77: 47-57.
9Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Int Med, 2004, 140: 167-174.
